Cardiovascular Disease

The American Heart Association has published a statement supporting the use of home dialysis over in-center dialysis for patients with kidney and cardiovascular disease.

Prediction models incorporating both cardiovascular disease and fracture risk factors may be able to predict the risk for major adverse CV events in adults with osteoporosis, according to study data.

Compared with men, women are at a higher risk of all-cause mortality in the first 5 years following dialysis initiation, according to data published in the American Journal of Kidney Diseases.

During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men.

Eicosapentaenoic acid at a dose of 4 g per day reduced effects of major depressive disorder in overweight individuals with elevated inflammatory markers better than placebo at 12 weeks, according to a recently published study.

Both abiraterone and enzalutamide appeared to increase risk for metabolic and cardiovascular adverse events among older men with advanced prostate cancer who previously underwent androgen deprivation therapy, according to study results.

The COVID-19 pandemic has had a profound effect on cardiology care, changing how, when and where physicians interact with their patients in ways large and small, seemingly overnight.

LOUISVILLE, Ky. — Persistent, chronic inflammation seen in moderate to severe psoriasis is associated with plaque destabilization and rupture that drives MI, and biologic treatment can reduce CV risk, according to a speaker.

New findings strengthen existing evidence demonstrating a link between cancer survival and CVD, particularly heart failure, according to researchers.

Salt substitutes consistently improved BP and lowered risk for mortality, CV mortality and CV events, according to a meta-analysis published in Heart.